American Society of Hematology

Policy News

Policy News
Subscribe to RSS
  • Update on Tax Reform Dec 20, 2017

    On December 20, the House of Representatives and the Senate voted to approve H.R. 1, tax reform legislation. Because the versions passed by the House and Senate differed, select members of each chamber came together in what is known as a conference committee to resolve disagreements between the two pieces of legislation. This final version of the legislation is the "conferenced" bill.

  • 2017 Action of the Affordable Care Act Dec 05, 2017

    Congress spent much of 2017 focused on the repeal and replace of the Affordable Care Act (ACA). Included is a summary of Congress and the Administration’s actions on repeal and replace of the ACA that occurred in 2017.

  • 2017 Research Advocacy Highlights Nov 29, 2017

    During 2017, ASH continued to be highly visible in our advocacy for federal support of biomedical research and funding for the National Institutes of Health.

  • 2017 Physician Payment Advocacy Highlights Nov 29, 2017

    In 2017, ASH commented on numerous rules and regulations proposed by the Centers for Medicare and Medicaid Services (CMS), which impact physician payment. ASH is actively involved in various advisory committees and also continues to engage with lawmakers on Capitol Hill.

  • 2017 ASH Advocacy Activities Nov 29, 2017

    ASH continues to increase its efforts to expand and enhance the Society’s reach. NIH funding, efforts to ensure patient access to drugs, and sickle cell disease were top priorities on ASH’s advocacy agenda in 2017.

  • 2017 ASH Advocacy Efforts to Ensure Patient Access to Care Nov 29, 2017

    ASH was very vocal on Congress’s repeated attempts to repeal and replace the Affordable Care Act (ACA). ASH opposed the legislation introduced in the House and the Senate and sent numerous letters to Congress outlining priorities and expressing concerns.

  • 2017 ASH Advocacy Efforts Related to Sickle Cell Disease and Sickle Cell Trait Nov 29, 2017

    ASH continues to invest in and explore the important actions needed to make a significant difference in sickle cell disease (SCD) access to care, research, and global issues. Learn about the major advocacy-related initiatives undertaken by ASH in 2017.

  • NCI Cancer Moonshot Funding Opportunities Align With ASH’s Research Priorities Nov 09, 2017

    ASH is pleased to see the National Cancer Institute’s (NCI) continuous support for research aimed at accelerating the prevention and treatment of cancers.

  • Executive Action on the ACA Oct 17, 2017

    After Congress repeatedly failed to pass legislation to repeal and replace the Affordable Care Act (ACA), President Trump used the power of the executive branch to make two significant changes to the law, both of which could have a substantial impact on access to care.

  • ASH Issues Recommendations for Pediatric Research Questions to NIH’s All of Us Research Program Sep 25, 2017

    ASH submitted comments to the NIH on hematology-related pediatric research that should be included in the NIH's All of Us research program.

1 of 35
back to top